What is IPF Phase III CAPACITY 1 (pirfenidone)?

Category: Others

true

Generic name: Pirfenidone

The CAPACITY 1 trial was a Phase III, placebo controlled trial of the safety and efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis. NCT00287729

No patients have reported taking IPF Phase III CAPACITY 1 (pirfenidone).
Last updated:
There are no evaluations for IPF Phase III CAPACITY 1 (pirfenidone).